Valeant Announces Closing Of Add-On Secured Notes And Credit Agreement Amendment
LAVAL, Quebec, Nov. 21, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has closed its previously announced offering (the "Offering") of $750,000,000 aggregate principal amount of its 5.500% senior secured notes due 2025 (the "Notes"). The Notes are additional notes and form part of the same series as Valeant's existing 5.500% senior secured notes due 2025. Valeant used the net proceeds from the offering of the Notes, along with cash on hand, to prepay (on a pro rata basis) a portion of its outstanding Series F Tranche B Term Loans due 2022 and to pay related fees and expenses.
Subsequent to the closing of the Offering and the related prepayment, the Company successfully completed the repricing of its Series F Tranche B Term Loans. The amendment reduces the annual interest rate on the Series F Tranche B Term Loans by 1.25% and makes certain other changes.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics.
(877) 281-6642 (toll free)
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-announces-closing-of-add-on-secured-notes-and-credit-agreement-amendment-300560140.html
SOURCE Valeant Pharmaceuticals International, Inc.
Why Investors Want to Believe in Shopify Inc (US) Stock
Yahoo 11/27 13:08 ET
EYEG: Cataract Surgery Study Completes Enrollment, Topline Data Expected Q1 18
Yahoo 11/27 12:00 ET
Quant Billionaire David Shaw Beats the Drum for Valeant Pharmaceuticals International, Inc. (VRX) and MannKind Corporation (MNKD)
Yahoo 11/27 10:35 ET
Don’t Bet on Shopify Inc (US) Stock
Yahoo 11/27 10:15 ET
Implied Volatility Surging for Valeant (VRX) Stock Options
Yahoo 11/24 08:33 ET
Today’s Research Reports on Stocks to Watch: Valeant Pharmaceuticals and Nutanix, Inc.
Yahoo 11/24 08:10 ET
Sector Update: Health Care Stocks Drifting Underwater
MT Newswires 11/22 13:06 ET
Valeant Closes Senior Note Offering, Reprices Term Loan
Yahoo 11/22 08:42 ET
MT Newswires After-Hours News Movers
MT Newswires 11/21 17:46 ET
Valeant Pharma Wraps $750 Mln Offering of 5.50% Senior Secured Notes Due 2025; Proceeds Will Pay Down Portion of Term Loan Facility
MT Newswires 11/21 16:47 ET